vs
Side-by-side financial comparison of Interactive Brokers Group, Inc. (IBKR) and ResMed (RMD). Click either name above to swap in a different company.
Interactive Brokers Group, Inc. is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× ResMed). Interactive Brokers Group, Inc. runs the higher net margin — 70.2% vs 27.6%, a 42.6% gap on every dollar of revenue. On growth, Interactive Brokers Group, Inc. posted the faster year-over-year revenue change (17.0% vs 11.0%). Over the past eight quarters, Interactive Brokers Group, Inc.'s revenue compounded faster (87.6% CAGR vs 7.8%).
Interactive Brokers, Inc. is an American multinational brokerage firm headquartered in Greenwich, Connecticut. It operates the largest electronic trading platform in the United States by number of daily average revenue trades. In 2024, the platform processed an average of 2.6 million trades per trading day. Interactive Brokers is the largest foreign exchange market broker and is one of the largest prime brokers servicing commodity brokers. The company brokers stocks, options, futures contract...
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
IBKR vs RMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.4B |
| Net Profit | $1.2B | $392.6M |
| Gross Margin | — | 61.8% |
| Operating Margin | — | 34.6% |
| Net Margin | 70.2% | 27.6% |
| Revenue YoY | 17.0% | 11.0% |
| Net Profit YoY | 21.5% | 13.9% |
| EPS (diluted) | $0.59 | $2.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.7B | $1.4B | ||
| Q4 25 | $667.0M | $1.4B | ||
| Q3 25 | $603.0M | $1.3B | ||
| Q2 25 | $578.0M | $1.3B | ||
| Q1 25 | $592.0M | $1.3B | ||
| Q4 24 | $558.0M | $1.3B | ||
| Q3 24 | $507.0M | $1.2B |
| Q2 26 | — | $392.6M | ||
| Q1 26 | $1.2B | $398.7M | ||
| Q4 25 | $1.2B | $392.6M | ||
| Q3 25 | $1.2B | $348.5M | ||
| Q2 25 | $1.0B | $379.7M | ||
| Q1 25 | $964.0M | $365.0M | ||
| Q4 24 | $969.0M | $344.6M | ||
| Q3 24 | $834.0M | $311.4M |
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% |
| Q2 26 | — | 27.6% | ||
| Q1 26 | 70.2% | 27.9% | ||
| Q4 25 | 180.1% | 27.6% | ||
| Q3 25 | 196.7% | 26.1% | ||
| Q2 25 | 174.0% | 28.2% | ||
| Q1 25 | 162.8% | 28.3% | ||
| Q4 24 | 173.7% | 26.9% | ||
| Q3 24 | 164.5% | 25.4% |
| Q2 26 | — | $2.68 | ||
| Q1 26 | $0.59 | $2.74 | ||
| Q4 25 | $-0.82 | $2.68 | ||
| Q3 25 | $0.59 | $2.37 | ||
| Q2 25 | $0.51 | $2.58 | ||
| Q1 25 | $1.94 | $2.48 | ||
| Q4 24 | $2.00 | $2.34 | ||
| Q3 24 | $1.67 | $2.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1B | $1.4B |
| Total DebtLower is stronger | $12.0M | $663.8M |
| Stockholders' EquityBook value | $5.6B | $6.3B |
| Total Assets | $218.7B | $8.5B |
| Debt / EquityLower = less leverage | 0.00× | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $1.4B | ||
| Q1 26 | $5.1B | $1.7B | ||
| Q4 25 | $5.0B | $1.4B | ||
| Q3 25 | $5.1B | $1.4B | ||
| Q2 25 | $4.7B | $1.2B | ||
| Q1 25 | $3.5B | $932.7M | ||
| Q4 24 | $3.6B | $521.9M | ||
| Q3 24 | $3.6B | $426.4M |
| Q2 26 | — | $663.8M | ||
| Q1 26 | $12.0M | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
| Q2 26 | — | $6.3B | ||
| Q1 26 | $5.6B | $6.5B | ||
| Q4 25 | $5.4B | $6.3B | ||
| Q3 25 | $5.1B | $6.1B | ||
| Q2 25 | $4.8B | $6.0B | ||
| Q1 25 | $4.5B | $5.5B | ||
| Q4 24 | $4.3B | $5.3B | ||
| Q3 24 | $4.1B | $5.2B |
| Q2 26 | — | $8.5B | ||
| Q1 26 | $218.7B | $8.8B | ||
| Q4 25 | $203.2B | $8.5B | ||
| Q3 25 | $200.2B | $8.3B | ||
| Q2 25 | $181.5B | $8.2B | ||
| Q1 25 | $157.7B | $7.6B | ||
| Q4 24 | $150.1B | $7.1B | ||
| Q3 24 | $148.5B | $7.2B |
| Q2 26 | — | 0.11× | ||
| Q1 26 | 0.00× | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
